The recent appointment of Pierre-Yves Jolivet as Executive Vice-President and Head of Eviden for Atos marked a significant leadership shift focused on cybersecurity. Over the last quarter, Atos experienced a substantial share price increase of 67%, amidst a tumultuous market that saw indices like the Nasdaq enter bear market territory due to geopolitical tensions and tariff concerns. This gain contrasts with broader market declines, supported by Atos securing a £150 million contract with DEFRA and forming a strategic partnership with Esri. The company's turnaround in net income, showcasing robust financial recovery, has also likely played a role. We've discovered 5 warning signs for Atos (4 make us uncomfortable!) that you should be aware of before investing here.ENXTPA:ATO Revenue & Expenses Breakdown as at Apr 2025 The end of cancer? These 21 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. Over the past year, Atos has seen a total shareholder return of 73.13% despite its recent turnaround. Key events include a challenging financial year highlighted by the Full Year Earnings Report released in March 2025. Atos reported a net income recovery to €248 million after a heavy loss the prior year and a revenue decline from €10.69 billion to €9.58 billion. This financial restructuring included a €233 million equity offering in November 2024, aimed at stabilizing its balance sheet and sustaining its operations. Additionally, Atos's contracts and partnerships, such as the one with DEFRA for a five-year £150 million service agreement announced in March 2025 and another with Banco Mercantil for cloud migration in January 2025, reflect efforts to enhance operational efficiency and growth potential. Despite these efforts, Atos underperformed the French Market and the French IT industry, which saw returns of 8% and 31.4% over the past year, respectively. Review our growth performance report to gain insights into Atos' future. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Story Continues Companies discussed in this article include ENXTPA:ATO. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
Atos (ENXTPA:ATO) Appoints Pierre-Yves Jolivet As Executive VP Amidst 2% Share Price Dip
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...